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How the epidermal growth factor receptor (EGFR)
activates is incompletely understood. The intracel-
lular portion of the receptor is intrinsically active in
solution, and to study its regulation, we measured
autophosphorylation as a function of EGFR surface
density in cells. Without EGF, intact EGFR escapes
inhibition only at high surface densities. Although
the transmembrane helix and the intracellular
module together suffice for constitutive activity
even at low densities, the intracellular module is inac-
tivated when tethered on its own to the plasma
membrane, and fluorescence cross-correlation
shows that it fails to dimerize. NMR and functional
data indicate that activation requires an N-terminal
interaction between the transmembrane helices,
which promotes an antiparallel interaction between
juxtamembrane segments and release of inhibition
by the membrane. We conclude that EGF binding re-
moves steric constraints in the extracellular module,
promoting activation through N-terminal association
of the transmembrane helices.
INTRODUCTION
Receptor tyrosine kinases, such as the epidermal growth factor
receptor (EGFR), play critical roles in regulating metabolism,
growth, and differentiation (Hubbard and Till, 2000; Lemmon
and Schlessinger, 2010). A single transmembrane helix in these
receptors connects an N-terminal extracellular ligand-bindingmodule to an intracellular tyrosine kinase domain. Ligand
binding increases catalytic activity in the kinase domains and
leads to phosphorylation of intracellular tyrosine residues. In
EGFR, these tyrosines are principally located in a longC-terminal
tail.
In this paper and in a companion paper in this issue of Cell
(Arkhipov et al., 2013), we examine how ligand binding to the
extracellular module of EGFR activates its kinase domains.
EGFR was the first growth factor receptor demonstrated to
undergo ligand-dependent dimerization (Yarden and Schles-
singer, 1987), and crystal structures have shown how ligand
binding promotes the dimerization of the extracellular module
(Ferguson et al., 2003; Garrett et al., 2002; Ogiso et al., 2002).
A critical step in EGFR activation is the formation of an asym-
metric dimer of kinase domains (Zhang et al., 2006), in which
the C-terminal lobe of one kinase domain (the activator) and
the N-terminal lobe of another kinase domain (the receiver) asso-
ciate, stabilizing an active conformation of the receiver kinase
domain (Zhang et al., 2006). Activation through asymmetric
homo- or heterodimerization underlies the combinatorial activa-
tion of EGFR and its close relatives Her2, Her3, and Her4 (Jura
et al., 2011; Yarden and Sliwkowski, 2001).
It is natural to think that ligand-driven dimerization of EGFR
simply converts inactive monomers into active dimeric recep-
tors, but the mechanism cannot be so simple. The isolated intra-
cellular module of the receptor (consisting of the juxtamembrane
segment, kinase domain, and C-terminal tail) is active at rela-
tively low concentrations in solution (<1 mM) (Jura et al., 2009;
Red Brewer et al., 2009; Thiel and Carpenter, 2007). This is
a consequence of the juxtamembrane segments stabilizing the
asymmetric dimer necessary for activity (Jura et al., 2009; Red
Brewer et al., 2009). The C-terminal portion of the juxtamem-
brane segment (denoted JM-B) of the receiver kinase latchesCell 152, 543–556, January 31, 2013 ª2013 Elsevier Inc. 543
Figure 1. Model for EGFR Activation and Domain Architecture
(A) Model for monomer-dimer equilibrium of EGFR in the absence and presence of EGF (Yarden and Schlessinger, 1987).
(B) EGFR constructs used in this study.onto the activator kinase domain (Figure 1A). The N-terminal
portion of the juxtamembrane segment (JM-A) is thought to
form an antiparallel helical association between subunits, further
stabilizing the asymmetric dimer (Jura et al., 2009; Scheck et al.,
2012). Clearly, the responsiveness of the receptor to ligand544 Cell 152, 543–556, January 31, 2013 ª2013 Elsevier Inc.implies that the intrinsic activity of the intracellular module is sup-
pressed in some way when the ligand is not bound.
EGFR family members are prone to ligand-independent
dimerization and activation at high expression levels (Nagy
et al., 2010). The coupled equilibria governing EGFR activation,
incorporating both ligand-independent and ligand-dependent
dimerization, are diagrammed in Figure 1A (Yarden and Schles-
singer, 1987). This diagram omits the formation of higher-order
oligomers (Clayton et al., 2008) and negative cooperativity in
ligand binding (Alvarado et al., 2010; Liu et al., 2012; Macdonald
and Pike, 2008), both of which are also likely to be important for
EGFR function.
We now present an experimental analysis of EGFR activation
aimed at understanding how the conformations of the extracel-
lular and intracellular module are coupled. The companion paper
presents the results of molecular dynamics simulations of the
receptor in lipid bilayers (Arkhipov et al., 2013), which provided
a framework for interpreting some of our experimental results.
We begin by using immunofluorescence to measure EGFR auto-
phosphorylation as a function of receptor surface density in cells.
Our data lead to the unexpected conclusion that the intrinsic
activity of the intracellular module is inhibited when it is tethered
to the plasma membrane. We show, using fluorescence cross-
correlation spectroscopy (FCCS), that the inhibition of the intra-
cellular module at the membrane is due to a failure to dimerize.
These data point to a critical role for the transmembrane helix
in dimerizing and activating the intracellular module, but the
role of the transmembrane helix in EGFR activation is poorly
understood (Lu et al., 2010, 2012;Moriki et al., 2001).We address
this by using NMR to analyze the structure of the transmembrane
and juxtamembrane segments of EGFR in lipid bilayers.
RESULTS AND DISCUSSION
Ligand-Independent Activation of EGFR Depends on the
Surface Density of the Receptor and Formation of the
Asymmetric Dimer
An essential part of our analysis is to determine the activity of the
receptor in cells as a function of its density on the plasma
membrane. To do this, we transiently transfected Cos-7 cells
with various EGFR constructs fused to mCherry, and monitored
phosphorylation at a specific residue in the C-terminal tail (Tyr
1068) using fluorescent phosphospecific antibodies (Figure 2A;
Experimental Procedures). Due to the morphology of Cos-7
cells, which resembles that of a fried egg, we could focus our
analysis on plasma-membrane-localized EGFR by selecting
regions at the periphery of the cells (Figure S1 available online).
By calibrating our microscope to relate the fluorescence inten-
sity of EGFR in these peripheral regions to its surface density
(Galush et al., 2008), we obtain a cell-by-cell quantification of
the relative tyrosine phosphorylation level as a function of the
surface density of EGFR at the plasma membrane (Figure S2A).
The dependence of EGFR activation on surface density, aver-
aged over many cells (100), is shown in Figure 2B for Tyr 1068.
In cells treated with EGF for short times (3–5 min) to minimize
receptor internalization (Sorkin and Goh, 2009), the relative
phosphorylation level per molecule is independent of the re-
ceptor surface density over the experimental range considered
(50–2,000 receptors per mm2) (right panel, Figure 2B). This indi-
cates that EGF binding is sufficient to trigger phosphorylation,
even at the lowest surface densities observed in our study.
In the absence of EGF, the relative phosphorylation level
per receptor increases with receptor surface density, reachingvalues at the highest densities that are comparable to those
obtained upon EGF stimulation. At a surface density of 1,400
receptors per mm2, the mean phosphorylation level of the unli-
ganded receptor is roughly half of that observed when EGF is
added (Figure 2B). This density is equivalent to a local concen-
tration of kinase domains of 200 mM (Extended Experimental
Procedures),100-fold higher than that required for robust acti-
vation of the intracellular module in solution (Jura et al., 2009).
The level of EGF-independent phosphorylation of the receptor
is essentially the same as the EGF-induced level when the sur-
face density of the receptor becomes higher than2,000 recep-
tors per mm2, which corresponds to 1.3 million receptors per
cell (Extended Experimental Procedures). This is comparable
to the levels of EGFR expression reported in cancer cells that
overexpress EGFR (Haigler et al., 1978).
EGF-independent activation at high expression levels requires
formation of the asymmetric dimer. Introduction of the V924R
mutation, which disrupts the interface between the activator
and receiver kinases in the asymmetric dimer (Zhang et al.,
2006), completely suppresses ligand-independent EGFR activity
in the range of surface densities examined (Figure S2C). There is
a modest increase in phosphorylation level upon EGF treatment
in cells expressing the V924R mutant, but this increase is inde-
pendent of surface density and is probably due to low levels of
endogenous EGFR.
A similar dependence of phosphorylation level on surface
density is seen when other tyrosine residues are monitored
(such as Tyr 1173, Figure S2B). We observe the same general
pattern when we examine these cells using fluorescence-acti-
vated cell sorting (FACS), with formation of the asymmetric dimer
being required (Figure S2D). Because FACS analysis does not
provide an easy way to distinguish between expression of con-
structs at the cell surface and on internal membranes, we focus
primarily on results from immunofluorescence microscopy.
The Extracellular Module Blocks Receptor Activation in
the Absence of Ligand
Deletion of the extracellular module activates EGFR, although
it is not clear whether this effect is restricted to high levels
of receptor expression (Chantry, 1995; Nishikawa et al., 1994;
Zhu et al., 2003). To address this, we measured phosphorylation
as a function of surface density for a construct of EGFR in which
the extracellular module is deleted, leaving just the transmem-
brane helix and the intracellular module (TM-ICM, Figures 1B
and 2C).
The TM-ICM construct does not localize solely to the plasma
membrane (Figure S2E). Nevertheless, by focusing on the
peripheral regions in these cells, we find that phosphorylation
of TM-ICM at the plasma membrane is much greater than for
the unliganded wild-type receptor, even at the lowest surface
densities studied (Figure 2C). As for the EGF-activated receptor,
the normalized phosphorylation level of TM-ICM does not
depend on its surface density, which is consistent with constitu-
tive activation.
To test the importance of the linkage between the extracellular
module and the transmembrane helix, we inserted a flexible
linker consisting of 20 glycine, serine, and threonine residues
between them (ECM-GlySer-TM-ICM, Figure 1B). This constructCell 152, 543–556, January 31, 2013 ª2013 Elsevier Inc. 545
Figure 2. Surface Density Dependence of EGFR Activation
(A) Fluorescence microscopy images of EGFR fused to mCherry expressed in Cos-7 cells (left, red) compared to phosphorylation level of EGFR at Tyr 1068
(middle panels, green, merged with expression in right panels). In bottom panels, cells were treated with EGF for 3 min at 37C prior to fixation (Experimental
Procedures).
(legend continued on next page)
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shows a substantial increase in ligand-independent phosphory-
lation at low receptor densities compared to the wild-type
receptor (Figure 2D), with similar localization (Figure S2E). This
is consistent with previous studies with a similar construct, in
cells overexpressing EGFR (Sorokin, 1995).
The Intracellular Module of EGFR Is Inhibited at the
Plasma Membrane
To test the role of the transmembrane helix in activation, we
generated a construct (Myr-ICM), which has the intracellular
module fused to a plasma membrane-targeting motif derived
from c-Src (Reuther et al., 2000; Silverman and Resh, 1992).
Given the high activity of the intracellular module in solution
(Jura et al., 2009) and previous suggestions that the transmem-
brane helix is likely to play a passive role in coupling to the extra-
cellular module (Lu et al., 2010, 2012), we expected that localiza-
tion of the intracellular module alone to the plasma membrane
would result in robust autophosphorylation, due to its high effec-
tive concentrations. Surprisingly, analysis of the surface density
dependence shows that Myr-ICM is substantially inhibited rela-
tive to the activated intact receptor (Figure 3A). Confocal images
confirm that this inhibition is not due to mislocalization because
Myr-ICM is strongly inhibited on the plasma membrane, relative
to the EGF-treated full-length receptor (Figure 3B).
The intracellular domain can be activated constitutively at
the plasma membrane by the insertion of the coiled-coil seg-
ment from the transcription factor GCN4 (O’Shea et al., 1991)
between the c-Srcmembrane-localizationmotif and the intracel-
lular module (Myr-GCN4-ICM, Figure 1B), which presumably
enforces dimerization (Figure 3A). In contrast, a construct in
which a flexible linker (GGGTGGGS) is inserted between the c-
Src motif and the juxtamembrane segment exhibited low activity
(Figure S3A), indicating that direct interference by the c-Srcmotif
is unlikely to be responsible for the inhibition of Myr-ICM.
Molecular dynamics simulations of inactive and unliganded
EGFR (Arkhipov et al., 2013) suggest two reasons for inhibition
of the intracellular module at the membrane (Figure 3C). First,
the JM-A segment interacts tightly with the membrane, with
three leucine side chains (located within an LRRLL motif) that
are at the heart of the antiparallel association that stabilizes
the asymmetric dimer, buried in the hydrophobic part of the
membrane. Second, negatively charged lipids in the membrane
interact extensively with positively charged side chains in the
kinase domain and the juxtamembrane segment, lending sup-
port to previous speculations that such interactions may inhibit
the receptor (McLaughlin et al., 2005).
Many of the membrane-interacting elements are important for
activation and substrate binding, so it is difficult to design muta-(B) Relationship between EGFR surface density and phosphorylation level. In the
mean phosphorylation level for selected cells with comparable surface density (
using linear and second-order polynomial fits for EGFR with and without ligand, re
level to surface density for all cells within equal ranges of surface densities (value o
ones, error bars represent SEM.
(C) Surface density-dependent phosphorylation for a construct with extracellular
(D) Surface density-dependent phosphorylation levels for a construct with a flex
(ECM-GlySer-TMICM) compared to EGFR.
Error bars represent SEM.
See also Figure S2.tions that do not compromise activation. We focused on four
lysine residues in the N-terminal lobe of the kinase domain
(residues 689, 692, 713, and 715) that do not appear to be
involved in the formation of the asymmetric dimer but are seen
to interact with the membrane in the simulations. Replacement
of two of these residues at a time with glutamate results in
substantial activation of the Myr-ICM construct in the immuno-
fluorescence microscopy assay (Myr-ICM K713E/K715E and
Myr-ICM K689E/K692E, Figures 3D and 3E), without affecting
membrane localization as judged by confocal imaging (Fig-
ure S3B). Introduction of the same mutations in the context of
the full-length receptor does not result in enhanced phosphory-
lation (data not shown). Thus, it appears that other inhibitory
interactions are dominant in the intact receptor.
The configuration of the EGFR kinase domain is likely to be
coupled to the configuration of the JM-A segment. We asked
what would happen if the JM-A segment was replaced by a flex-
ible linker. We replaced 12 residues in the JM-A segment by
a flexible linker consisting of three repeats of the motif Gly-
Gly-Gly-Ser (ECM-TM-GlySer-ICM, Figure 1B). This construct
retains the JM-B segment, which stabilizes the active asym-
metric dimer by forming the ‘‘juxtamembrane latch.’’ The ECM-
TM-GlySer-ICM construct is strongly inhibited both in the
absence and presence of EGF at densities as high as 2,000
molecules per mM2 (or 300 mM effective concentration) (see
Figure 3F), which is consistent with the idea that inhibitory inter-
actions between the kinase domains and the plasma membrane
play a role in preventing ligand-independent activation.
The IntracellularModule Is PredominantlyMonomeric at
the Plasma Membrane
These results led us to wonder whether dimerization of the
intracellular module is prevented at the plasma membrane. To
assess the level of oligomerization of various EGFR constructs
in live cells, we used two-color pulsed-interleaved excitation
fluorescence cross-correlation spectroscopy (PIE-FCCS), in
which a pair of lasers alternately excites GFP and mCherry
with subnanosecond pulses (Mu¨ller et al., 2005) (Figure 4A).
Diffusion of individual molecules in and out of the diffraction-
limited laser focus gives rise to fluorescence intensity fluctua-
tions, from which we calculate a cross-correlation value that is
proportional to the fraction of codiffusing molecules (Larson
et al., 2005) (Figure S4A). Correlated diffusion observed with
PIE-FCCS is a rigorous indicator of molecular association and
is not affected by random, dynamic collisions and crowding
effects that complicate FRET-based assays. In contrast to con-
ventional FCCS, PIE-FCCS detects the arrival time of each
photon (Becker et al., 2005), enabling unambiguous assignmentleft panel, individual data points represent the mean surface density and the
within 100 molecules per mm2 of the mean value). Trend lines were calculated
spectively. In the right panel, bars represent the mean ratio of phosphorylation
n x axis ±250 molecules per mm2). In these diagrams, as well as all subsequent
domain deleted (TM-ICM) compared to EGFR with or without EGF.
ible linker inserted between the extracellular module and the transmembrane
Cell 152, 543–556, January 31, 2013 ª2013 Elsevier Inc. 547
Figure 3. Activity of the Intracellular Module Localized to the Plasma Membrane with the c-Src Motif
(A) Surface density dependence of phosphorylation for Myr-ICM compared to EGF-treated EGFR and Myr-GCN4-ICM.
(B) Confocal fluorescence microscopy images of cells expressing EGFR (top) or the intracellular module fused to a c-Src membrane localization motif (Myr-ICM,
bottom), showing expression levels (left, red) and antibody detection of phosphorylation at Tyr 1068 (middle panels, green, merged with expression in right
panels). Large panels are images in the x-y plane of the basal surface of the cells (closest to the coverslip). Smaller panels are projections in the x-z plane,
orthogonal to the basal surface, at the y coordinate indicated by the white arrow. Note that, whereas expression of Myr-ICM is higher than EGFR, its phos-
phorylation level is significantly lower.
(C) Schematicmodel for docking of the EGFR kinase domain against the plasmamembrane based onmolecular dynamics simulations of unliganded EGFR in lipid
bilayers (Arkhipov et al., 2013). In the kinase domain, positively charged residues that interact with negatively charged lipids during the simulations are labeled and
shown as blue dots. The LRRLL motif in the JM-A segment is shown in stick form, with leucines in green and arginines in blue.
(legend continued on next page)
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Figure 4. FCCS Data for EGFR Constructs
on the Plasma Membrane
(A) Schematic of laser excitation and fluorescence
detection for two-color PIE-FCCS (left). Pulse
diagram (right) showing excitation pulses (top, with
GFP in blue and mCherry in green) and emission
(bottom, with GFP in green and mCherry in red) is
shown. Note that time gating allows us to eliminate
mCherry emission when GFP is excited.
(B) Relative cross-correlation values for various
EGFR constructs. Myr-FP is a coexpression of
GFP and mCherry, each fused separately to the
c-Src membrane localization motif. Data are rep-
resented as a scatterplot, with the red line repre-
senting the median value. Surface densities of
EGFR constructs ranged from 100–1,000 mole-
cules per mm2.
See also Figure S4.of each detected photon to an excitation laser source. This
ensures that any cross-correlation we observe is due to codiffu-
sion and not spectral crosstalk (Figure S4B; Extended Experi-
mental Procedures) (Mu¨ller et al., 2005).
To determine the extent to whichMyr-ICMdimerized, we com-
pared its cross-correlation values to that of the Myr-GCN4-ICM(D) Surface density dependence of phosphorylation for charge-reversal mutations in the N-lobe interaction r
K715E), compared to Myr-ICM and EGF-treated EGFR.
(E) Surface density dependence of phosphorylation for another set of charge-reversal mutations in the N-lob
and EGF-treated EGFR. The data for EGFR and Myr-ICM are the same as in Figure 3D because samples w
(F) Surface density dependence of phosphorylation for ECM-TM-GlySer-ICM and EGFR in the absence and
Error bars represent SEM.
See also Figures S1 and S3.
Cell 152, 543–556construct (Figure 4B), which is constitu-
tively active (Figure 3A) and presumably
dimerized by the GCN4 coiled coil. The
cross-correlation values for Myr-ICM are
comparable to those for a monomeric
control, in which GFP and mCherry,
each fused to the c-Src localization
sequence, are coexpressed (Figure 4B).
The cross-correlation values for Myr-
GCN4-ICM are significantly higher than
for Myr-ICM and are roughly half that ob-
tained for a fusion of GFP and mCherry in
one protein (Figure S4C), consistent with
it being a dimer (in a random population
of dimers, 50% should be GFP, mCherry
pairs). Differences in cross-correlation
between Myr-ICM and Myr-GCN4-ICM
do not change significantly over the range
of densities we observe (100–1,000 mole-
cules per mm2) (Figure S4D). Although the
precise oligomeric state cannot be deter-
mined from cross-correlation values, our
results demonstrate that Myr-ICM oligo-
merization is inhibited relative to that of
Myr-GCN4-ICM on the plasma mem-brane and that it is likely to be monomeric over the range of
surface densities examined.
The cross-correlation values for unliganded full-length EGFR
are similar to those for the monomeric controls, indicating that
the intact receptor is also predominantly monomeric in the
same range of surface densities for which ligand-independentegion of the intracellular domain (Myr-ICM K713E/
e (Myr-ICM K689E/K692E), compared to Myr-ICM
ere prepared on the same day.
presence of EGF.
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Figure 5. NMR Structure of Transmembrane-Juxtamembrane Dimer in Bicelles and Role of N-Terminal Dimer Interface in Receptor
Activation
(A) Structural model of the transmembrane-juxtamembrane segment of EGFR in DMPC/DHPC bicelles as determined from NMR data. Intermolecular NOESY
connectivities are shown with gray lines. Dimer interfaces are expanded in the right panels.
(B) Expanded view of the transmembrane dimer interface with residues in the small-small-x-x-small-small motif highlighted.
(legend continued on next page)
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activation is suppressed (less than 1,000 receptors per mm2).
Treatment with saturating levels of EGF significantly increases
cross-correlation values, indicating that EGF binding increases
the oligomeric state of the receptor. This EGF-induced increase
in clustering does not depend on the kinase activity of the re-
ceptor (Figure S4E). The cross-correlation values for EGF-stimu-
lated EGFR are, on average, less than expected for a constitutive
dimer, based on comparison to Myr-GCN4-ICM. This may be
due a reduction in the ability of EGF to access EGFR on the basal
membrane, which is adhered to the glass surface, as suggested
by confocal images in which phosphorylation of Tyr1068 in EGF-
treated cells is stronger on the apical membrane (Figure 3B). Our
results are consistent with amonomer-to-dimer transition driving
EGFR activation at low surface densities.
Structural Analysis of the Transmembrane and the
Juxtamembrane Segments in Lipid Bilayers
The transmembrane helix must be critical for activation because
its presence converts the inactive intracellular module to an
active form at low surface densities. In order to understand the
structural basis for this, we used NMR to analyze a fragment
of EGFR spanning the transmembrane helix and the first
29 residues of the juxtamembrane segment (TM-JM, residues
618–673), reconstituted in lipid bicelles made from 1,2-dimyris-
toyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-dihexanoyl-
sn-glycero-3-phosphocholine (DHPC). These bicelles have
been used previously to analyze the transmembrane helices of
EGFR and HER2 (Bocharov et al., 2008; Mineev et al., 2010).
Nearly all (98%) of the backbone resonances of the TM-
JM construct in the membrane were assigned using standard
TROSY-based double- and triple-resonance experiments (Ex-
tended Experimental Procedures). The NMR data for the trans-
membrane helix are consistent with previous reports describing
dimeric structures (Bocharov et al., 2008; Mineev et al., 2010)
(Figures 5 and S5). In addition, the NMR analysis provides
evidence for the formation of a helix by the LRRLL motif in the
JM-A segment.
We measured intermolecular NOEs between isotopically
labeled and unlabeled proteins incorporated into lipid bicelles
in two different sets of experiments (Extended Experimental
Procedures) (Tables S1 andS2; Figure S5). The 21 intermolecular
NOEs we measured were not enough to determine the con-
figuration of the TM-JM segment unambiguously, so we used
observations from molecular dynamics simulations of the TM-
JM segment in DMPC lipid bilayers (Arkhipov et al., 2013). These
simulations indicated that two of theNOEsweobserved are likely
to arise from a less-populated alternative configuration of the
transmembrane helix and so were removed in our determination
of the NMR-based model for the TM-JM segment (Figures 5A
and S6; Extended Experimental Procedures; Tables S1 and S2).
The dimerization interface utilizes a classical transmembrane
dimerization motif (commonly referred to as a ‘‘GxxxG’’ motif,(C) Surface density dependence of phosphorylation for EGFRwith four residues in
and mutant EGFR are compared with or without EGF treatment.
(D) FACS data comparing EGFR expression level (x axis) to Tyr 1068 phosphory
Error bars represent SEM.
See also Figures S5 and S6.although the residues represented by G can be any residue
with a small side chain) (Lemmon et al., 1994). The transmem-
brane helices of the catalytically active members of the EGFR
family contain GxxxG motifs at each end of the helix (Fleishman
et al., 2002). EGFR has two overlapping N-terminal GxxxG
motifs, resulting in a small-small-x-x-small-small motif, with the
small side chains facing the dimer interface in our structure (Fig-
ure 5B). This interface is similar to that observed for Her2 (Bo-
charov et al., 2008) and is consistent with disulfide crosslinking
studies of EGFR (Lu et al., 2010).
The right-handed crossing angle of 44 ± 3 in our NMR
model results in separation of the C-terminal ends of the trans-
membrane helices by 20 A˚ and provides the appropriate
spacing for an antiparallel interaction between the JM-A helices
(Figure 5A). As demonstrated by the intermolecular NOE con-
nectivity, this interface is formed by the side chains of Leu 655,
Leu 658, and Leu 659, located within the LRRLL motifs of the
two subunits (Figure 5A). These helices interact with each other
outside the lipid bilayer, as judged by the NMR-derived water
accessibility of the juxtamembrane residues (Figure S5A).
Disruption of the N-Terminal Dimerization Motif of the
Transmembrane Helix Inhibits EGFR Activity
The activity of EGFR is insensitive to replacement of essentially
any residue in the transmembrane segment by other hydro-
phobic residues (Lu et al., 2010). EGFR activity is not affected
significantly even if two of the interfacial residues in the
N-terminal dimerization motif are replaced simultaneously by
isoleucine (G625I/A629I; data not shown). In contrast, mutating
all four of the small residues in the N-terminal interface to isoleu-
cine (4I, T624I/G625I/G628I/A629I) results in significant inhibi-
tion of EGFR, as seen by immunofluorescence microscopy and
by FACS analysis (Figures 5C and 5D). These results, which
are also consistent with observations from molecular dynamics
simulations (Arkhipov et al., 2013), provide evidence for the
importance of the N-terminal association between transmem-
brane helices in receptor activation.
We also sought to disrupt the N-terminal association of the
transmembrane helices by stabilizing interactions through the
C-terminal dimerization motif, which has been suggested to
underlie autoinhibition of the receptor (Fleishman et al., 2002).
We mutated Ile 640, located within the C-terminal dimerization
motif, to glutamate, which is expected to stabilize its association
(Sternberg and Gullick, 1989).
We examined the effect of this mutation on the TM-JM con-
struct in lipid bicelles by NMR. The I640E mutation results in
significant chemical shift perturbations throughout the TM-JM
construct (Figures 6A and 6B). In particular, chemical shifts for
the Cb atoms of Ala 629 and Ala 637 in the N- terminal and
C-terminal dimerization motifs, respectively, are altered (Fig-
ure 6B). We also observe chemical shift changes in the LRRLL
motif in the JM-A segment. The I640E mutation does not perturbthe N-terminal interfacemutated (4I, T624I/G625I/G628I/A629I). Bothwild-type
lation level for wild-type EGFR and the 4I mutant.
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Figure 6. The Effect of the I640E Mutation on Transmembrane Helix Structure and Receptor Activation
(A) 1H, 15N chemical shift differences between the I640Emutant and the wild-type TM-JM segment for each residue. The solid (red) and dashed (black) horizontal
lines represent the chemical shift differences expected based on the digital resolution of the spectra and calculated from the average chemical shift, respectively.
The vertical red dashed lines represent the predicted membrane-spanning region, based on the sequence analysis.
(B) The Ala Cb region from the
1H-13C (CT) HSQC spectra of the wild-type and I640E TM-JM segments in DMPC/DHPC bicelles, respectively. Schematic
representation of the C-terminal dimer is shown at the right, with the uniformly labeled helix on the left and unlabeled one on the right. Residues examined in NMR
or cell-based experiments are highlighted.
(legend continued on next page)
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the sequential NOE connectivity (dNN(i,i+1)) or
13Ca secondary
structure-induced chemical shifts (DCa) for the transmembrane
helix, suggesting that the helical nature of this segment is unaf-
fected (Figure S7).
Wemeasured intermolecular NOEs between labeled and unla-
beled TM-JM constructs with the I640E mutation using isotope-
filtered NOESY experiments. One of the hallmarks of the
N-terminal interface, an NOE between the Ha and Hb atoms of
Ala 629 on different helices (Figure S5G), is missing in the
I640E mutant, consistent with disruption of the N-terminal inter-
face. Instead, we observe intermolecular NOEs between the Ha
and Hb atoms of Ala 637, and between the Hb atom of Ala 637
and the HN atom of Gly 639 across the C-terminal interface (Fig-
ure 6C). Thus, dimerization of the transmembrane helices in the
I640E mutant brings the residues in the C-terminal dimerization
motif into close proximity, although NMR data and molecular
dynamics simulations suggest that the dimer formed by the
I640E mutant is less stable than the wild-type dimer (Figure S7C)
(Arkhipov et al., 2013).
The NMR data demonstrate that disruption of the N-terminal
interface between the transmembrane helices is correlated
with disruption of the antiparallel JM-A interaction. We do not
observe any sequential NOE connectivity (dNN(i,i+1)) or intermo-
lecular NOE connectivity for the juxtamembrane segment in the
I640E mutant (Figure S7A), indicating a loss of structure in this
region. Molecular dynamics simulations of the TM-JM construct
in lipid bilayers also indicate that the formation of a C-terminal
transmembrane interface is incompatible with formation of the
juxtamembrane dimer interface (Arkhipov et al., 2013).
Whenwe introduce the I640Emutation into the intact receptor,
EGF-dependent activation is impaired significantly in compar-
ison to that of the wild-type EGFR (Figure 6D). Additionally,
the constitutive activity of the TM-ICM construct is reduced
substantially by introduction of the I640E mutation, as shown
by FACS (Figure 6E). These results suggest that interaction of
the transmembrane helices through their N-terminal dimerization
motif, coupled to formation of an antiparallel interaction between
JM-A helices, is essential for activation of the EGFR kinase
domain.
Conclusions
The presence of the juxtamembrane segment dimerizes the iso-
lated intracellular module of EGFR in solution, suggesting that
the principal function of ligand binding to the intact receptor is
to change the structure of the extracellular module such that it
does not impede the intrinsic ability of the intracellular module
to activate (Jura et al., 2009). Unexpectedly, we find that ligand
binding must also play a role in altering the conformation of
the transmembrane helix and the JM-A segment to promote
receptor activation because the intracellular module is mono-(C) Representative 2D strip plot showing the Ala 637 Hb intermolecular NOE cross
NOESY-HSQC spectra.
(D) Surface density dependence of phosphorylation for the I640E mutation in full
EGF treatment.
(E) FACS data comparing expression level (x axis) to Tyr 1068 phosphorylation le
Error bars represent SEM.
See also Figure S7.meric and inhibited when it is localized to the plasma membrane
on its own.
Our NMRanalysis shows that the formation of the JM-A helix is
coupled to the configuration of the transmembrane helices and
occurs outside of the membrane. Molecular dynamics simula-
tions suggest that when EGFR is in an inactive conformation,
the LRRLL motif within the JM-A segment is buried in the mem-
brane (Arkhipov et al., 2013), consistent with NMR data for the
isolated juxtamembrane segment of EGFR in detergent micelles
(Choowongkomon et al., 2005). These observations suggest that
the nature of the interaction between the transmembrane helices
toggles the configuration and membrane association of the
JM-A portion of the juxtamembrane segments (Figure 7A).
A recent cell-based study clearly links an antiparallel interac-
tion between the JM-A helices to EGFR activation and not just
dimerization (Scheck et al., 2012). We propose that the JM-A
segments need to be pulled off the membrane in order to
promote the asymmetric interaction between kinase domains.
The latch formed by the JM-B segment of the receiver on the
C-lobe of the activator kinase domain positions the side chain
of Glu 666 of the receiver near Arg 949 of the activator, providing
an anchor point for the C-terminal end of the receiver JM-A
segment (Red Brewer et al., 2009; Wood et al., 2008). In a crystal
structure of the EGFR intracellular module with an intact juxta-
membrane segment, the JM-A helix is anchored at this point
but is directed away from the surface of the activator kinase by
crystal lattice contacts (Red Brewer et al., 2009). We believe,
instead, that the polar face of the JM-A helix of the receiver inter-
acts with the surface of the kinase domain, as modeled earlier by
Jura et al. (2009) and seen consistently in themolecular dynamics
simulations. If the receiver JM-A helix is docked in this way, then
the leucine residues of the LRRLLmotif point up from the surface
of the kinase domain and are available for interaction with the
activator JM-A helix, as shown schematically in Figure 7B. Our
NMR data suggest that dimerization of the transmembrane heli-
ces through the N-terminal interface facilitates this arrangement.
Molecular dynamics simulations indicate that the extracellular
module of EGFR prevents the close approach of the trans-
membrane helices that would be required for interaction through
the N-terminal dimerization motif (Arkhipov et al., 2013), even
when the receptor is dimerized in the absence of ligand. Consis-
tent with this idea, ligand-independent activation of the receptor
can be increased when flexible linkers are inserted between the
extracellular module and the transmembrane helix. Thus, we
believe that an essential role for EGF in receptor activation is
to cause a specific conformational change in the extracellular
modules that allows the transmembrane helices to interact
through their N-terminal interface.
A striking feature of the activation mechanism is the strong co-
operativity between the external, internal, and transmembrane-peak at the 13C frequency of Ala 637 Cb, from 3D
15N-13C F1-filtered/F3-edited
-length EGFR. Both wild-type and mutant EGFR are compared with or without
vel for the TM-ICM construct, with or without the I640E mutation.
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Figure 7. Models for Structural Coupling
(A) Model for structural coupling between the
transmembrane helices and the juxtamembrane
segments (JM-A) at the plasma membrane, based
on NMR data and molecular dynamics simulations
(Arkhipov et al., 2013). The LRRLL motif in JM-A is
highlighted, with leucine side chains in green and
yellow and arginines in blue.
(B) Model for asymmetric dimer formation at
the plasma membrane. The surface of the kinase
domains and the backbone of the juxtamembrane
segments are shown. Residues in the LRRLL motif
in the JM-A are shown as sticks, with leucine in
yellow (activator) or green (receiver) and arginine in
blue. Glu 666 of the receiver and Arg 949 of the
activator are also shown.segments of EGFR. We speculate that, because the EGFR
dimer interface is mediated entirely by the receptor itself,
selective pressure for inhibitory mechanisms to prevent ligand-
independent activation has been particularly strong. At the
same time, because EGFR signaling requires a specific dimeric
configuration of kinase domains, there must also be selective
pressure to stabilize that configuration. The balance of these
competing requirements may have driven the evolution of coun-
terbalanced-activating and inhibiting mechanisms that minimize
ligand-independent activation and facilitate the formation of
appropriate heterodimers in response to external cues.
EXPERIMENTAL PROCEDURES
Mammalian Cell-Based Assays
For immunofluorescence experiments, Cos-7 cells were grown on etched
glass coverslips, transfected with FuGENE (Promega) and serum starved.
When noted, cells were treated with EGF (100 ng/ml; PeproTech) for 3 min
at 37C. After fixation in 2% formaldehyde, permeabilization with 0.1% Triton554 Cell 152, 543–556, January 31, 2013 ª2013 Elsevier Inc.X-100, and blocking with 0.2% BSA, cells were
stained with Tyr 1068 primary antibody (Cell
Signaling) and then anti-rabbit fluorescein-labeled
(FITC) antibody (Sigma-Aldrich). Cells were
mounted with Thermomount (Thermo Scientific)
with 0.2% trans-pyridine-2-azo-p-dimethylaniline
(Sigma-Aldrich) for immunofluorescence or with
Prolong Gold (Invitrogen) for confocal imaging.
For live and confocal imaging, cells were grown
in glass bottom dishes (Matek). Samples for flow
cytometry were prepared similarly to immunofluo-
rescence microscopy with an additional step of
dissociating cells with trypsin before fixation.
See Extended Experimental Procedures for more
detailed protocols.
Analysis of Phosphorylation as a Function
of Expression Level
Cells were imaged with a TE-2000 Nikon fluores-
cence microscope with a xenon lamp through a
603 TIRF objective (Nikon Instruments) with stan-
dard filters (Extended Experimental Procedures).
The microscope was calibrated for mCherry inten-
sity using lipid bilayers containing Texas red lipids
and mCherry purified from E. coli as described
by Galush et al. (2008). For each cell, the mean
values for both mCherry intensity and FITCintensity were measured in selected peripheral regions and corrected for
background using ImageJ (Schneider et al., 2012). Calculation of the phos-
phorylation level per receptor included correction for background phosphor-
ylation levels in cells expressing low levels of EGFR (less than 100 molecules
per mm2), and normalization to EGFR levels for samples fixed on the same day
(Extended Experimental Procedures).
Fluorescence Correlation Spectroscopy
Fluorescence correlation spectroscopy measurements used a custom-modi-
fied inverted microscope (Nikon Eclipse Ti; Nikon Instruments). A 200-fs-
pulsed, 560 nm laser beam was synced with a 100-ps-pulsed, 482 nm diode
laser and delayed by 50 ns. Both lasers were coupled into a single-mode
optical fiber and then collimated to a 4 mm beam diameter. Samples were
excited through a 1003 objective (CFI APO 100X Oil TIRF NA 1.49; Nikon
Instruments), with laser powers of1 mWmeasured before the objective. Fluo-
rescence emitted from the sample is directed to a long wave-pass dichroic
beamsplitter (FF562-Di02-25 3 36; Semrock) and on to a pair of band-
pass-filtered single-photon avalanche diodes (PDM module; Optoelectronic
Components). Detector output was measured with a time-correlated single-
photon-counting module (PicoHarp 300; PicoQuant Photonics), with a time
resolution of 32 ps (Extended Experimental Procedures). Measurements
were made at the cell periphery, and we explicitly avoided large (>1 mm), high-
intensity features.
Each detected photon is tagged with its absolute arrival time, and the delay
time with respect to the laser pulses. Photons are collated into 10 ms time bins
after being sorted by detector channel and arrival time. This generates a time-
dependent fluorescence signal, free from green-to-red bleed-through, FRET,
and direct mCherry excitation by the 482 nm laser. Fluorescence correlation
and cross-correlation spectra are calculated as described in the Extended
Experimental Procedures.
NMR Spectroscopy
The transmembrane-juxtamembrane segment (TM-JM, residues 618–673) of
EGFR was purified from inclusion bodies (Extended Experimental Proce-
dures). The NMR sample was prepared by dissolving the purified protein in
deuterated TFE and then mixing with deuterated DMPC and DHPC lipids
(Avanti Polar Lipids). The protein and the lipids were mixed in a ratio of
1:150, and the DMPC-to-DHPC ratio was set at 0.25. The final NMR sample
(at a protein concentration of 0.3 mM) was prepared by resuspending the
protein and the lipid mixture in a sample buffer containing 50 mM MES (pH
6.2), 5 mM TCEP, 1 mM EDTA, 0.05 mM ABESF, 7% 2H2O, 0.02% NaN3.
All NMR experiments were performed at 1H frequencies of 600 or 900 MHz
on Bruker Avance spectrometers fitted with TCI cryoprobes. The backbone
chemical shift assignments were obtained through TROSY-based triple-reso-
nance experiments (Kay et al., 2011; Pervushin et al., 1997; Salzmann et al.,
1998). Intermolecular NOEswere resolved by 3D 15N-13C F1-filtered/F3-edited
NOESY-HSQC and methyl 13C-edited NOESY-HSQC experiments (Breeze,
2000; Stuart et al., 1999). The backbone amide resonances for the I640E
mutant were assigned using TROSY HNCA, 13C (CT)-HSQC spectra, and 3D
NOESY experiments. The structural model for the TM-JM dimer was gener-
ated using the simulated annealing protocol of CNS (v.1.3) (Brunger, 2007).
A detail description of the NMRmethods and structure calculation is provided
in the Extended Experimental Procedures.
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